Analytic Investors’s Integra LifeSciences IART Stock Holding History

Analytic Investors’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-19,300	Closed	-$531K	–	594
2015 Q2	$531K	Sell	19,300 -11,660	-38%	-$311K	0.01%	451
2015 Q1	$780K	Hold	30,960	–	–	0.01%	399
2014 Q4	$686K	Hold	30,960	–	–	0.01%	396
2014 Q3	$628K	Buy	30,960 +11,696	+61%	+$233K	0.01%	431
2014 Q2	$371K	Hold	19,264	–	–	0.01%	447
2014 Q1	$362K	Hold	19,264	–	–	0.01%	493
2013 Q4	$376K	Hold	19,264	–	–	0.01%	416
2013 Q3	$317K	Buy	+19,264	New	+$309K	0.01%	448

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Analytic Investors's IART Position: Q3 2015 in Review

Analytic Investors sold out of Integra LifeSciences (IART) in Q3 2015, closing a stake of 19,300 shares — an estimated $531K sold.

Analytic Investors first reported a position in IART in Q3 2013 and held it in 8 quarters. The position peaked at $780K in Q1 2015. 189 funds tracked by Wall St. Rank hold IART as of Q3 2015.

Analytic Investors reported no remaining Integra LifeSciences position as of Q3 2015 after selling out during the quarter.
Analytic Investors sold 19,300 Integra LifeSciences shares in Q3 2015, an estimated $531K.
Analytic Investors first reported a position in Integra LifeSciences in Q3 2013 and held it in 8 quarters.
Analytic Investors's Integra LifeSciences position peaked at $780K in Q1 2015.
189 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2015.

Based on Analytic Investors's 13F filing for Q3 2015, filed 12 Nov 2015.